Published in Obesity and Diabetes Week, October 9th, 2006
This long-term clinical trial is the second study conducted at European clinical centers demonstrating that exenatide can control blood sugar as effectively as insulin.
During the 1-year (52-week) study, which enrolled 501 participants, patients using exenatide showed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week